BioSpace News Archive

How to Write a Stellar Resignation Letter

In order to do this without burning bridges and ensure that employees have all their references intact, a resignation letter must be created.

December 12, 2019
·
3 min read
·
Kymberlie Krieger
Career Advice

The Job Search Checklist to Complete Before the New Year

If you’re planning on looking for a new job at the beginning of the year, now is the time to start your job search prep.

December 12, 2019
·
2 min read
·
Laura Brothers
Business

Karuna Therapeutics: New Approaches to Psychosis in Schizophrenia and Alzheimer’s

Karuna’s work is primarily focused on psychosis related to schizophrenia and late-stage Alzheimer’s disease, as well as analgesic effects for pain.

December 12, 2019
·
6 min read
·
Mark Terry
Policy

Alkermes Ad for Opioid Addiction Treatment Omits Safety Information, FDA Says

The U.S. Food and Drug Administration issued a warning letter to the company for misbranding its opioid addiction medication Vivitrol in promotional materials.

December 12, 2019
·
2 min read
·
Alex Keown
Biotech Beach

Researchers ID Molecule that Appears to Halt and Reverse Scarring in Fibrotic Diseases

Researchers at the University of California-Los Angeles Health Sciences have developed a scar-in-a-dish model derived from stem cells that can mimic fibrosis.

December 12, 2019
·
2 min read
·
Mark Terry
Business

BioSpace Movers & Shakers, Dec. 13

Pharma and biotech companies strengthen their leadership teams and boards with this week’s hires.

December 12, 2019
·
5 min read
·
Alex Keown
Policy

MagForce AG: ‘NanoTherm School’ successfully enters its second round with Module B

MagForce successfully hosted the second session of its practice-oriented, unique, multifaceted application training for the use of the NanoTherm therapy system in treating brain tumors

December 12, 2019
·
5 min read
Business

Start Codon and One Nucleus partner to support UK life science ecosystem

Start Codon cohort companies to receive One Nucleus membership benefits

December 12, 2019
·
1 min read
Business

Inceptua Appoints New CEO

Inceptua announced that Stefan Fraenkel has been appointed CEO effective 1 January 2020.

December 12, 2019
·
3 min read
Drug Development

Positive Trastuzumab Trial Data Offers Hope for Struggling Breast Cancer Patients

AstraZeneca and Daiichi Sankyo presented positive data from their Phase II single-arm DESTINY-Breast01 trial of trastuzumab deruxtecan (DS-8201) in HER2-positive metastatic breast cancer patients who received two or more previous HER-2 targeted regimens.

December 12, 2019
·
2 min read
·
Mark Terry